Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction

被引:114
作者
Leeda, M
Riyazi, N
de Vries, JIP
Jakobs, C
van Geijn, HP
Dekker, GA
机构
[1] Free Univ Amsterdam Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, NL-1081 HV Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands
关键词
hyperhomocysteinemia; preeclampsia; fetal growth restriction; pregnancy;
D O I
10.1016/S0002-9378(98)70263-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to assess the incidence of hyperhomocysteinemia in patients with a history of preeclampsia or fetal growth restriction, to evaluate the effects of vitamin supplementation on the methionine loading test, and to study the course of subsequent pregnancies in women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. STUDY DESIGN: A total of 207 consecutive patients with a history of preeclampsia or fetal growth restriction was tested for hyperhomocysteinemia. Thirty-seven were found to be positive and were treated with folic acid and vitamin B-6, and 27 had a second methionine loading test after vitamin supplementation. Fourteen patients became pregnant again while receiving vitamins and aspirin. RESULTS: All patients who underwent a methionine loading test after vitamin supplementation had a completely normalized methionine loading test. Of the 14 pregnancies in women receiving vitamins and aspirin, 7 were complicated by preeclampsia. Birth weights were 2867 +/- 648 g compared with 1088 +/- 570 g in the previous pregnancies. CONCLUSIONS: Vitamin B-6 and folic acid correct the methionine loading test in patients with hyperhomocysteinemia. Perinatal outcome in patients with a history of preeclampsia or fetal growth restriction and hyperhomocysteinemia appears to be favorable.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 23 条
[1]  
BOERS GHJ, 1986, CLIN RES SERIES, V3, P52
[2]  
BRIGGS GG, 1994, DRUGS PREGNANCY LACT, P747
[3]  
BRIGGS GG, 1994, DRUGS PREGNANCY LACT, P378
[4]  
BURKE G, 1992, NEW ENGL J MED, V326, P69
[5]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[6]  
Dekker GA, 1996, J PERINAT MED, V24, P99
[7]   UNDERLYING DISORDERS ASSOCIATED WITH SEVERE EARLY-ONSET PREECLAMPSIA [J].
DEKKER, GA ;
DEVRIES, JIP ;
DOELITZSCH, PM ;
HUIJGENS, PC ;
VONBLOMBERG, BME ;
JAKOBS, C ;
VANGEIJN, HP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (04) :1042-1048
[8]   Endothelial dysfunction in preeclampsia .2. Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; Therapeutic perspectives [J].
Dekker, GA ;
vanGeijn, HP .
JOURNAL OF PERINATAL MEDICINE, 1996, 24 (02) :119-139
[9]  
*DEP HLTH WELSH OF, 1991, REP CONF EQ MAT DEAT
[10]   MATERNAL MORTALITY ASSOCIATED WITH HYPERTENSIVE DISORDERS OF PREGNANCY IN AFRICA, ASIA, LATIN-AMERICA AND THE CARIBBEAN [J].
DULEY, L .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 (07) :547-553